COVID-19 - International Pharmaceutical Industry

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

News

ILC Therapeutics raises £3.5m to advance lead interferon drug candidate

UK-based biotech company ILC Therapeutics has announced the successful completion of a £3.5m pre-IPO funding round. In a statement, ILC Therapeutics – which is fo...

8 September 2021 News Alfacyte | COVID-19

Continue Reading →

News

CMA launches formal investigation into COVID-19 PCR test firm

The UK’s Competitions and Markets Authority (CMA) has launched a formal investigation into private firm Expert Medicals, following complaints relating to its provisi...

8 September 2021 News CMA | Competitions and Markets Authority

Continue Reading →

News

FDA approves first COVID-19 vaccine

The U.S. Food and Drug Administration approved the first COVID-19 vaccine. The vaccine has been known as the Pfizer-BioNTech COVID-19 Vaccine, and will now be market...

25 August 2021 News COVID-19 | emergency use authorization

Continue Reading →

News

Moderna’s COVID-19 vaccine maintains antibodies to six months, study shows

New data published on the durability of the Moderna COVID-19 vaccine in generating neutralising antibodies against variants of concern has shown that the majority of...

13 August 2021 News COVID-19 | Moderna

Continue Reading →

News

Further clinical trial planned for Valneva’s COVID-19 vaccine candidate

Valneva is planning to initiate a further Phase III trial (VLA2001-304) for its inactivated, adjuvanted COVID-19 vaccine candidate, VLA2001. The new VLA2001-304 s...

13 August 2021 News COVID-19 | elderly

Continue Reading →